Venture Map · Round
Integra Therapeutics — Seed · €4.5M
Announced 2021-12-02 · Barcelona · Biotech / Gene editing
Integra Tx is a Pompeu Fabra University spin-off developing next-generation gene-writing tools. It closed a €4.5M first round led by Advent France Biotechnology with Invivo Capital and Takeda Ventures, to complete its prototype and run preclinical validation in 2022-2023.
RoundSeed
Amount€4.5M
LeadAdvent France Biotechnology
Date2021-12-02
CityBarcelona
SectorBiotech / Gene editing
The company
Investors 3
A
Advent France Biotechnology
I
Invivo Capital
TTakeda Ventures